Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9126967rdf:typepubmed:Citationlld:pubmed
pubmed-article:9126967lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C2698599lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C0104998lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C1705431lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:9126967lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:9126967pubmed:issue9lld:pubmed
pubmed-article:9126967pubmed:dateCreated1997-5-19lld:pubmed
pubmed-article:9126967pubmed:abstractTextThe costimulatory signal provided to T cells through CD28/CTLA-4 interactions is required for in vivo Th cell effector function associated with cytokine production. However, it is uncertain whether the two well-characterized ligands for these molecules, B7-1 and B7-2, differentially influence the consequent development of a type 1 or a type 2 primary response. We have examined the in vivo effects of blocking B7-1 and/or B7-2 ligand interactions on the type 2 mucosal immune response that follows oral infection of mice with the nematode parasite, Heligmosomoides polygyrus. Administration of the combination of anti-B7-1 and anti-B7-2 Abs inhibited H. polygyrus-induced increases in serum IgG1 and IgE levels, the expansion of mesenteric lymph node (MLN) germinal centers, in situ CD4+ T cell expansion, elevated blood eosinophils, and increased intestinal mucosal mast cells. Similarly, both Abs blocked MLN and Peyer's patch cytokine gene expression and elevations in MLN T cell-derived IL-4 protein secretion. However, in the same experiments, administration of either anti-B7-1 or anti-B7-2 Abs alone had little effect on any of these parameters. T cell and B cell activation was also blocked by the combination of anti-B7-2 and a B7-1-specific mutant Y100F CTLA-4Ig construct. These results suggest that to the extent that anti-B7-1 and anti-B7-2 mAbs block B7 interactions, either B7-1 or B7-2 ligand interactions can provide the required costimulatory signals that lead to T cell effector function during a type 2 in vivo immune response.lld:pubmed
pubmed-article:9126967pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:languageenglld:pubmed
pubmed-article:9126967pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9126967pubmed:statusMEDLINElld:pubmed
pubmed-article:9126967pubmed:monthMaylld:pubmed
pubmed-article:9126967pubmed:issn0022-1767lld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:ChenSSlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:FinkelmanF...lld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:MorrisS CSClld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:ZhouXXlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:LinsleyP SPSlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:LuPPlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:UrbanJ FJFJrlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:PeachRRlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:GauseW CWClld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:MaddenK BKBlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:HalvorsonM...lld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:PerrinP JPJlld:pubmed
pubmed-article:9126967pubmed:authorpubmed-author:GreenwaldR...lld:pubmed
pubmed-article:9126967pubmed:issnTypePrintlld:pubmed
pubmed-article:9126967pubmed:day1lld:pubmed
pubmed-article:9126967pubmed:volume158lld:pubmed
pubmed-article:9126967pubmed:ownerNLMlld:pubmed
pubmed-article:9126967pubmed:authorsCompleteYlld:pubmed
pubmed-article:9126967pubmed:pagination4088-96lld:pubmed
pubmed-article:9126967pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:meshHeadingpubmed-meshheading:9126967-...lld:pubmed
pubmed-article:9126967pubmed:year1997lld:pubmed
pubmed-article:9126967pubmed:articleTitleEffects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response.lld:pubmed
pubmed-article:9126967pubmed:affiliationDepartment of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.lld:pubmed
pubmed-article:9126967pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9126967pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9126967pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9126967lld:pubmed